Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID Reference, 4th edition, 372 pages

+ the daily Top 10


  Free Subscription


4 Ann Intern Med
1 J Infect Dis
2 J Virol
3 Lancet
1 Lancet Gastroenterol Hepatol
1 Lancet HIV
2 N Engl J Med
1 Nat Med
2 PLoS One
1 Proc Natl Acad Sci U S A
3 Science
16 Vaccine

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Ann Intern Med

  1. FREEDMAN M, Kroger A, Hunter P, Ault KA, et al
    Recommended Adult Immunization Schedule, United States, 2020.
    Ann Intern Med. 2020;172:337-347.

    SARS-CoV-2 Vaccine Acceptance: We May Need to Choose Our Battles.
    Ann Intern Med. 2020 Sep 4. doi: 10.7326/M20-6206.

  3. FISHER KA, Bloomstone SJ, Walder J, Crawford S, et al
    Attitudes Toward a Potential SARS-CoV-2 Vaccine: A Survey of U.S. Adults.
    Ann Intern Med. 2020 Sep 4. doi: 10.7326/M20-3569.
    PubMed         Abstract available

  4. HVIID A
    Vaccine Safety in Pregnancy: Going Beyond the Perinatal Period.
    Ann Intern Med. 2020 Sep 1. doi: 10.7326/M20-5489.


    Covid-19: US will not join WHO in developing vaccine.
    BMJ. 2020;370:m3396.

  6. HVIID A, Thorsen NM, Valentiner-Branth P, Frisch M, et al
    Association between quadrivalent human papillomavirus vaccination and selected syndromes with autonomic dysfunction in Danish females: population based, self-controlled, case series analysis.
    BMJ. 2020;370:m2930.
    PubMed         Abstract available

    Midwives, paramedics, and physiotherapists could deliver covid and flu vaccines under government plan.
    BMJ. 2020;370:m3375.

    J Infect Dis

  8. BLUMENFELD O, Hampe CS, Shulman LM, Chen R, et al
    An Attenuation in the Incidence of Early Childhood Diabetes Correlates With Introduction of Rotavirus Vaccination in Israel.
    J Infect Dis. 2020 Sep 1. pii: 5900392. doi: 10.1093.

    J Virol

  9. HUANG Y, Owino SO, Crevar CJ, Carter DM, et al
    N-Linked Glycans and K147 Residue on Hemagglutinin Synergize to Elicit Broadly-Reactive H1N1 Influenza Antibodies.
    J Virol. 2019 Dec 18. pii: JVI.01432-19. doi: 10.1128/JVI.01432.
    PubMed         Abstract available

  10. SILVA DE CASTRO I, Gordon SN, Liu J, Bissa M, et al
    Expression of CD40L by the ALVAC-SIV vector abrogates T cell responses in macaques.
    J Virol. 2020 Jan 2. pii: JVI.01933-19. doi: 10.1128/JVI.01933.
    PubMed         Abstract available


  11. AVORN J, Kesselheim A
    Regulatory Decision-making on COVID-19 Vaccines During a Public Health Emergency.
    JAMA. 2020 Aug 31. pii: 2770244. doi: 10.1001/jama.2020.17101.

  12. THOMSON K, Nachlis H
    Emergency Use Authorizations During the COVID-19 Pandemic: Lessons From Hydroxychloroquine for Vaccine Authorization and Approval.
    JAMA. 2020 Aug 31. pii: 2770243. doi: 10.1001/jama.2020.16253.


  13. AIYEGBUSI OL, Calvert MJ
    Patient-reported outcomes: central to the management of COVID-19.
    Lancet. 2020 Aug 10. pii: S0140-6736(20)31724.

  14. DASHRAATH P, Nielsen-Saines K, Madhi SA, Baud D, et al
    COVID-19 vaccines and neglected pregnancy.
    Lancet. 2020 Aug 27. pii: S0140-6736(20)31822.

  15. KRAUSE P, Fleming TR, Longini I, Henao-Restrepo AM, et al
    COVID-19 vaccine trials should seek worthwhile efficacy.
    Lancet. 2020 Aug 27. pii: S0140-6736(20)31821.

    Lancet Gastroenterol Hepatol

    Eliminating viral hepatitis in the COVID-19 era: weighing challenge and opportunity.
    Lancet Gastroenterol Hepatol. 2020 Jul 27. pii: S2468-1253(20)30237.

    Lancet HIV

  17. VEKEMANS J, Snow W, Fast PE, Baggaley R, et al
    HIV immunoprophylaxis: preparing the pathway from proof of concept to policy decision and use.
    Lancet HIV. 2019 Nov 27. pii: S2352-3018(19)30294.
    PubMed         Abstract available

    N Engl J Med

  18. KEECH C, Albert G, Cho I, Robertson A, et al
    Phase 1-2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine.
    N Engl J Med. 2020 Sep 2. doi: 10.1056/NEJMoa2026920.
    PubMed         Abstract available

  19. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Operation Warp Speed and Covid-19.
    N Engl J Med. 2020;383:e79.

    Nat Med

  20. TOSTANOSKI LH, Wegmann F, Martinot AJ, Loos C, et al
    Ad26 vaccine protects against SARS-CoV-2 severe clinical disease in hamsters.
    Nat Med. 2020 Sep 3. pii: 10.1038/s41591-020-1070.
    PubMed         Abstract available

    PLoS One

  21. ZHAO XN, Zhang HJ, Li D, Zhou JN, et al
    Whole-genome sequencing reveals origin and evolution of influenza A(H1N1)pdm09 viruses in Lincang, China, from 2014 to 2018.
    PLoS One. 2020;15:e0234869.
    PubMed         Abstract available

  22. REUBEN R, Aitken D, Freedman JL, Einstein G, et al
    Mistrust of the medical profession and higher disgust sensitivity predict parental vaccine hesitancy.
    PLoS One. 2020;15:e0237755.
    PubMed         Abstract available

    Proc Natl Acad Sci U S A

  23. DEARLOVE B, Lewitus E, Bai H, Li Y, et al
    A SARS-CoV-2 vaccine candidate would likely match all currently circulating variants.
    Proc Natl Acad Sci U S A. 2020 Aug 31. pii: 2008281117.
    PubMed         Abstract available


  24. EMANUEL EJ, Persad G, Kern A, Buchanan A, et al
    An ethical framework for global vaccine allocation.
    Science. 2020 Sep 3. pii: science.abe2803. doi: 10.1126/science.abe2803.
    PubMed         Abstract available

  25. Erratum for the Report "Generation of influenza A viruses as live but replication-incompetent virus vaccines" by L. Si, H. Xu, X. Zhou, Z. Zhang, Z. Tian, Y. Wang, Y. Wu, B. Zhang, Z. Niu, C. Zhang, G. Fu, S. Xiao, Q. Xia, L. Zhang, D. Zhou.
    Science. 2020;369.

  26. YUAN M, Liu H, Wu NC, Lee CD, et al
    Structural basis of a shared antibody response to SARS-CoV-2.
    Science. 2020 Jul 13. pii: science.abd2321. doi: 10.1126/science.abd2321.
    PubMed         Abstract available


  27. CALZETTA L, Pistocchini E, Ritondo BL, Roncada P, et al
    Immunoprophylaxis pharmacotherapy against canine leishmaniosis: A systematic review and meta-analysis on the efficacy of vaccines approved in European Union.
    Vaccine. 2020 Aug 31. pii: S0264-410X(20)31092.
    PubMed         Abstract available

  28. HARAPAN H, Wagner AL, Yufika A, Setiawan AM, et al
    Acceptance and willingness to pay for a hypothetical vaccine against monkeypox viral infection among frontline physicians: A cross-sectional study in Indonesia.
    Vaccine. 2020 Aug 26. pii: S0264-410X(20)31075.
    PubMed         Abstract available

  29. PAGET J, Caini S, Cowling B, Esposito S, et al
    The impact of influenza vaccination on the COVID-19 pandemic? Evidence and lessons for public health policies.
    Vaccine. 2020 Aug 19. pii: S0264-410X(20)31065.

  30. GIUFRE M, Lindh E, Cardines R, Pezzotti P, et al
    Invasive Haemophilus influenzae type b (Hib) disease in children in Italy, after 20 years of routine use of conjugate Hib vaccines.
    Vaccine. 2020 Aug 25. pii: S0264-410X(20)31061.
    PubMed         Abstract available

  31. MALTEZOU HC, Theodoridou K, Poland G
    Influenza immunization and COVID-19.
    Vaccine. 2020 Jul 29. pii: S0264-410X(20)30989.

  32. PADILLA-QUIRARTE HO, Badillo-Godinez O, Gutierrez-Xicotencatl L, Acevedo-Betancur Y, et al
    Targeting M2e to DEC-205 induces an enhanced serum antibody-dependent heterosubtypic protection against influenza A virus infection.
    Vaccine. 2019 Apr 4. pii: S0264-410X(19)30257.
    PubMed         Abstract available

  33. REITER PL, Pennell ML, Katz ML
    Acceptability of a COVID-19 vaccine among adults in the United States: How many people would get vaccinated?
    Vaccine. 2020 Aug 20. pii: S0264-410X(20)31084.
    PubMed         Abstract available

  34. TOMITA Y, Sato R, Ikeda T, Sakagami T, et al
    BCG vaccine may generate cross-reactive T cells against SARS-CoV-2: In silico analyses and a hypothesis.
    Vaccine. 2020 Aug 20. pii: S0264-410X(20)31086.
    PubMed         Abstract available

  35. TALAYEV V, Zaichenko I, Svetlova M, Matveichev A, et al
    Low-dose influenza vaccine Grippol Quadrivalent with adjuvant Polyoxidonium induces a T helper-2 mediated humoral immune response and increases NK cell activity.
    Vaccine. 2020 Aug 29. pii: S0264-410X(20)30984.
    PubMed         Abstract available

  36. MCCOLLUM ED, Ahmed S, Roy AD, Chowdhury NH, et al
    Effectiveness of the 10-valent pneumococcal conjugate vaccine against radiographic pneumonia among children in rural Bangladesh: A case-control study.
    Vaccine. 2020 Aug 29. pii: S0264-410X(20)31076.
    PubMed         Abstract available

  37. KASE T, Inoue M, Morikawa S, Kumashiro H, et al
    Comparison of immunogenicity between candidate influenza A(H3N2) virus vaccine strains in Japan: A randomized controlled trial using a monovalent vaccine of A/Saitama/103/2014 (CEXP-002) and A/Hong Kong/4801/2014 (X-263).
    Vaccine. 2020 Aug 29. pii: S0264-410X(20)31066.
    PubMed         Abstract available

  38. SHERWOOD J, Mendelman PM, Lloyd E, Liu M, et al
    Efficacy of an intramuscular bivalent norovirus GI.1/GII.4 virus-like particle vaccine candidate in healthy US adults.
    Vaccine. 2020 Aug 30. pii: S0264-410X(20)31013.
    PubMed         Abstract available

  39. MARCHETTI RL, Gallucci-Neto J, Kurcgant D, Proenca ICGF, et al
    Immunization stress-related responses presenting as psychogenic non-epileptic seizures following HPV vaccination in Rio Branco, Brazil.
    Vaccine. 2020 Aug 30. pii: S0264-410X(20)31085.
    PubMed         Abstract available

  40. FINDLOW J, Bayliss CD, Beernink PT, Borrow R, et al
    Broad vaccine protection against Neisseria meningitidis using factor H binding protein.
    Vaccine. 2020 Aug 30. pii: S0264-410X(20)31072.
    PubMed         Abstract available

  41. SWAMY GK, Metz TD, Edwards KM, Soper DE, et al
    Safety and immunogenicity of an investigational maternal trivalent group B streptococcus vaccine in pregnant women and their infants: Results from a randomized placebo-controlled phase II trial.
    Vaccine. 2020 Aug 31. pii: S0264-410X(20)31108.
    PubMed         Abstract available

  42. AMIN AB, Nunes MC, Tapia MD, Madhi SA, et al
    Immunogenicity of influenza vaccines administered to pregnant women in randomized clinical trials in Mali and South Africa.
    Vaccine. 2020 Aug 28. pii: S0264-410X(20)30933.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Vaccines is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.